GH Capital Inc. (OTCPK:GHHC) entered into a share exchange agreement to acquire Vitana-X, INC. on August 21, 2019. The GH Capital agreed to issue to 1 million shares of Series B Preferred stock, to the respective shareholders of the common stock of Vitana-X. This agreement may be terminated by any party after December 31, 2019, by the mutual agreement between both of the parties. Pursuant to the agreement the shareholders of Vitana-X shall exchange their shares for shares of the GH Capital as the holders of the common stock of Vitana-X shall receive 100% of the shares of newly designated Series B Preferred Shares in exchange for each share of Common Stock of Vitana-X, on a pro rata basis. The shares of Vitana-X as of the date of this agreement consists of 74 shareholders of Vitana-X holding exactly 68,515,124 shares of Common Stock. The GHHC Series B Preferred Shares shall convert into a total amount equaling 80% of the total issued and outstanding common shares, post conversion, on a pro rata basis, which the Board of Directors has recommended to the shareholders. The Series B Preferred Share have no voting rights. Pursuant to the completion of the transaction, Vitana-X will become a wholly owned subsidiary of the GH Capital. The closing of the Agreement was further conditioned upon the Wolfgang Ruecker, William Bollander, Bane Katic and William Eilers shall resign as Directors of the GH Capital and the Matthias Goeth, Bernhard Sammer and Dirk Richter shall be appointed to the Board of Directors. William Eilers of Eilers Law Group, P.A. acted as legal advisor to GH Capital.